Skip to main content
. 2020 Jan 9;146(3):237–246. doi: 10.1001/jamaoto.2019.4193

Table 1. Demographic Characteristics of Patients.

Characteristic Patients, % Proportion Difference (95% CI)
All (N = 126 766) Postoperative Hypocalcemia 30-d Initial Treatment Period
Present (n = 24 159) Absent (n = 102 607)
Pathologic finding
Nodule 1.5 1.2 1.6 −0.4 (−1.7 to 1.0)
Goiter 37.8 33.1 38.9 −5.8 (−6.9 to −4.7)
Thyroiditis 10.5 11.8 10.2 1.5 (0.2 to 2.8)
Cancer 50.2 53.9 49.3 4.6 (3.6 to 5.6)
Age, y
18-39 29.4 33.8 28.4 5.4 (4.2 to 6.5)
40-64 70.6 66.2 71.6 −5.4 (−6.2 to −4.6)
Sex
Male 18.4 14.9 19.2 −3.4 (−5.6 to −3.1)
Female 81.6 85.1 80.8 4.3 (3.8 to 4.9)
Comorbidity score
0 93.0 91.8 93.3 −1.6 (−2.0 to −1.1)
1 5.9 6.9 5.7 1.2 (−0.2 to 2.5)
2 0.9 1.1 0.8 0.3 (−1.1 to 1.7)
≥3 0.2 0.2 0.2 0.1 (−1.3 to 1.5)
Procedure location
Inpatient 33.8 40.0 32.3 7.6 (6.8 to 8.5)
Outpatient 66.2 60.0 67.7 −7.6 (−8.7 to −6.5)
Region
Northeast 21.6 21.1 21.7 −0.6 (−1.8 to 0.7)
North central 21.1 21.8 20.9 0.9 (−0.4 to 2.1)
South 39.4 38.9 39.6 −0.6 (−1.7 to 0.5)
West 17.9 18.1 17.8 0.3 (−0.1 to 1.5)
Census median income quintilea
Very low 19.9 18.7 20.2 −1.5 (−2.8 to −0.1)
Low 20.1 22.2 19.6 2.6 (1.2 to 3.9)
Medium 20.0 20.9 19.8 1.1 (−0.2 to 2.5)
High 19.7 20.1 19.6 0.5 (−0.9 to 1.8)
Very high 20.3 18.1 20.8 −2.7 (−4.1 to −1.3)
Payera
Comprehensive 2.0 2.1 2.1 0 (−1.5 to 1.5)
HMO 16.0 14.0 16.4 −2.4 (−3.7 to −1.0)
POS 8.3 6.8 8.6 −1.8 (−3.3 to −0.5)
PPO 66.3 69.3 65.6 3.7 (2.9 to 4.5)
Other 7.4 7.8 7.3 0.5 (−0.9 to 1.9)
MSA volumea
Low 33.8 33.6 33.8 −0.2 (−1.5 to 0.1)
Medium 34.0 33.8 34.1 −0.3 (−1.5 to 0.1)
High 32.2 32.6 21.1 0.5 (−0.7 to 1.7)
Central neck dissection
Yes 15.9 19.1 15.1 4.0 (2.7 to 5.2)
No 84.1 80.9 84.9 −4.0 (−4.5 to −3.3)
Lateral neck dissection
Yes 6.9 10.1 6.2 3.9 (2.6 to 5.2)
No 93.1 89.9 93.8 −3.9 (−4.4 to −3.5)
Parathyroid reimplantation
Yes 10.1 14.5 9.0 5.5 (4.1 to 6.8)
No 89.9 85.5 91.0 −5.5 (−5.9 to −4.9)
Postoperative radiotherapy
Yes 6.5 7.6 6.2 1.4 (0.1 to 2.8)
No 93.5 92.4 93.8 −1.4 (−1.8 to −1.1)
Postoperative radioactive iodine
Yes 29.0 32.9 28.1 4.8 (3.6 to 5.9)
No 71.0 67.1 71.9 −4.8 (−5.5 to −3.9)
RLN injury
Yes 2.2 3.2 2.0 1.2 (−0.2 to 2.5)
No 97.8 96.8 98.0 −1.2 (−1.4 to −0.9)
Vitamin D deficiency
Yes 3.7 6.4 3.1 3.3 (2.9 to 4.7)
No 96.3 93.6 96.9 −3.3 (−3.7 to −2.9)
Menopause
Yes 0.9 1.0 0.9 0.1 (−2.3 to 1.5)
No 99.1 99.0 99.1 −0.1 (−0.2 to 0)
Magnesium disorder
Yes 2.1 7.4 0.8 6.6 (5.2 to 7.9)
No 97.9 92.6 99.2 −6.6 (−6.9 to −6.2)
Phosphate disorder
Yes 0.3 1.2 0.1 1.1 (−0.2 to 2.5)
No 99.7 98.8 99.9 −1.1 (−1.3 to −1.0)
Disposition
Routine 32.1 37.9 30.7 7.2 (6.0 to 8.3)
Short-term hospital <0.1 <0.1 <0.1
Other facility <0.1 <0.1 <0.1
Home health care 0.4 0.7 0.4 0.3 (−1.10 to 1.7)
Left against medical advice 0.1 0.2 0.1 0.1 (−0.5 to 0.7)
Died in hospital <0.1 <0.1 <0.1
Alive, destination unknown 67.3 61.2 68.7 −7.6 (−8.4 to −6.7)
Readmission within 30 d
Yes 3.9 11.1 2.3 8.8 (7.4 to 10.2)
No 96.1 88.9 97.7 −8.8 (−9.2 to −8.4)

Abbreviations: HMO, health maintenance organization; MSA, metropolitan statistical area; POS, point of service; PPO, preferred provider organization; RLN, recurrent laryngeal nerve.

a

Not known for all patients.